Candriam S.C.A. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001537014

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeTechnology TiltHigh Turnover how tags are computed

Q1 2025 · 648 positions · Total reported value $15.68B · Top-10 concentration 29.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.4% · 21 new · 252 cut · 51 exited

Active Share (vs S&P 500): 37.1% · vs QQQ: 52.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -0.6% · vs SPY -2.8% · Prev Value $22.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $22.25B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Candriam S.C.A. disclosed 648 equity positions with a combined reported value of $15.68B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.7% of reported value. HoldingsHub classifies the profile as Large / Technology Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were MSFT ($995.50M), NVDA ($796.13M), AAPL ($757.16M). By sector, the heaviest allocations are Technology 36.6%, Health Care 21.1%. Versus the prior quarter, allocation shifted toward Real Estate (+1.8pp), Health Care (+1.0pp) and away from Technology (-1.2pp), Other (-1.7pp).

Versus the prior quarter, Candriam S.C.A. opened 21 new positions, trimmed 252 and fully exited 51, a turnover rate of 47.4% of positions. The portfolio's overlap with the prior quarter was 86% of names.

The largest new positions opened in Q1 2025 were ONC ($77.81M), CRDO ($29.26M), EGO ($27.28M).

Of the 51 positions fully exited versus the prior quarter, the largest were ALTR ($67.03M), YPF ($19.57M), NU ($19.42M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • ONC BEONE MEDICINES LTD · $77.81M
  • CRDO CREDO TECHNOLOGY GROUP HOLDI · $29.26M
  • EGO ELDORADO GOLD CORP NEW · $27.28M
  • BSAC BANCO SANTANDER CHILE NEW · $25.12M
  • PATH UIPATH INC · $18.44M
  • CRNX CRINETICS PHARMACEUTICALS IN · $16.40M
  • WPC WP CAREY INC · $14.95M
  • BZ KANZHUN LIMITED · $10.97M

Fully Exited (vs previous quarter)

  • ALTR ALTAIR ENGINEERING INC CLASS A A · prev qtr: $67.03M
  • YPF YPF · prev qtr: $19.57M
  • NU NU HLDGS LTD · prev qtr: $19.42M
  • TD TORONTO DOMINION BK ONT · prev qtr: $19.29M
  • THC TENET HEALTHCARE CORP · prev qtr: $17.92M
  • ITCI INTRA CELLULAR THERAPIES INC · prev qtr: $17.90M
  • PLRX PLIANT THERAPEUTICS INC · prev qtr: $11.85M
  • MNSO MINISO GROUP HLDG LTD · prev qtr: $9.99M

Insider Transactions (Form 4)

Latest Candriam S.C.A. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Candriam S.C.A. is a Luxembourg-based asset management firm founded in 1989, now part of New York Life Investments, with headquarters in Strassen, Luxembourg. The firm employs a responsible investment approach integrating ESG factors across various asset classes.

Investment Approach

Responsible investment with ESG integration, combining quantitative and fundamental research, offering both active and passive investment strategies

Asset Classes

Equities, fixed income, alternatives, multi-asset solutions

Notable Facts

Part of New York Life Investments, strong focus on sustainable investing, acquired in 2018

AUM

$154.7B (SEC Form ADV regulatory figure)

Official disclosures available through SEC filings

Sector Allocation

Technology 36.6%
Health Care 21.1%
Financials 9.0%
Utilities 2.9%
Other 3.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.65M $995.50M 6.35%
6.35%
Reduce
2 7.35M $796.13M 5.08%
5.08%
Add
3 3.41M $757.16M 4.83%
4.83%
Reduce
4 2.67M $412.36M 2.63%
2.63%
Reduce
5 480.85K $397.14M 2.53%
2.53%
Reduce
6 2.07M $394.40M 2.52%
2.52%
Add
7 466.51K $255.71M 1.63%
1.63%
Reduce
8 1.31M $223.68M 1.43%
1.43%
Add
9 378.73K $218.28M 1.39%
1.39%
Add
10 422.35K $210.16M 1.34%
1.34%
Add
11 1.18M $196.87M 1.26%
1.26%
Add
12 724.23K $194.35M 1.24%
1.24%
Add
13 2.15M $192.85M 1.23%
1.23%
Reduce
14 764.31K $187.49M 1.20%
1.20%
Hold
15 534.03K $187.16M 1.19%
1.19%
Reduce
16 775.43K $179.52M 1.15%
1.15%
Reduce
17 1.57M $176.42M 1.12%
1.12%
Reduce
18 349.93K $173.31M 1.11%
1.11%
Add
19 506.20K $157.71M 1.01%
1.01%
Reduce
20 922.35K $153.11M 0.98%
0.98%
Add
21 291.76K $152.81M 0.97%
0.97%
Reduce
22 914.79K $142.92M 0.91%
0.91%
Reduce
23 372.69K $136.59M 0.87%
0.87%
Add
24 214.94K $136.32M 0.87%
0.87%
Reduce
25 795.69K $135.78M 0.87%
0.87%
Add
26 515.99K $133.72M 0.85%
0.85%
Add
27 1.05M $114.72M 0.73%
0.73%
Reduce
28 122.94K $97.88M 0.62%
0.62%
Reduce
29 198.29K $96.13M 0.61%
0.61%
Reduce
30 1.11M $96.12M 0.61%
0.61%
Add
31 333.02K $94.25M 0.60%
0.60%
Reduce
32 334.66K $87.61M 0.56%
0.56%
Add
33 321.24K $86.43M 0.55%
0.55%
Reduce
34 402.52K $84.99M 0.54%
0.54%
Add
35 639.07K $84.77M 0.54%
0.54%
Add
36 401.50K $84.12M 0.54%
0.54%
Reduce
37 498.76K $82.12M 0.52%
0.52%
Hold
38 121.40K $81.70M 0.52%
0.52%
Add
39 309.96K $78.58M 0.50%
0.50%
Reduce
40 432.98K $78.52M 0.50%
0.50%
Reduce
41 642.96K $78.31M 0.50%
0.50%
Reduce
42 285.89K $77.81M 0.50%
0.50%
New
43 332.22K $76.95M 0.49%
0.49%
Add
44 37.57K $73.30M 0.47%
0.47%
Add
45 282.98K $71.97M 0.46%
0.46%
Reduce
46 14.88K $68.54M 0.44%
0.44%
Add
47 183.27K $68.22M 0.43%
0.43%
Add
48 1.10M $66.81M 0.43%
0.43%
Reduce
49 981.89K $66.62M 0.42%
0.42%
Reduce
50 130.83K $66.48M 0.42%
0.42%
Add

FAQ

What did Candriam S.C.A. buy in 2025-Q1?

In its 2025-Q1 13F filing, Candriam S.C.A. reported 648 equity positions worth $15.68B in aggregate; its largest disclosed positions were MSFT ($995.50M), NVDA ($796.13M), AAPL ($757.16M).

How large is Candriam S.C.A.'s portfolio?

Candriam S.C.A. reported $15.68B of long equity holdings across 648 positions as of 2025-Q1. Top-10 holdings account for 29.7% of reported value.

What is Candriam S.C.A.'s investment style?

HoldingsHub classifies the portfolio as Large / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/candriam-s-c-a/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →